Yelee Kwon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yelee Kwon has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Jae Kwang Yun
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
4 shared publications- Pil Je Kang
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3 shared publications - Won Chul Cho
Department of Thoracic and Cardiovascular Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
3 shared publications - Yong-Hee Kim
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
3 shared publications - Chong Bin Park
Department of Thoracic and Cardiovascular Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
2 shared publications Geun Dong Lee
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 57 (4) , 981-988
Long-term Survival Outcomes of Surgical Resection for Lung Adenocarcinoma with Intraoperatively Diagnosed Pleural Metastasis: Target Treatment Era
Purpose This study aimed to evaluate the clinical impact of main tumor resection on long-term survival compared with pleural biopsy alone in patients with lung adenocarcinoma who were intraoperatively diagnosed with pleural metastasis.Materials and Methods A total of 176 patients with adenocarcinoma who had unexpected pleural metastasis detected during surgery from 2002 to 2021 were retrospectively analyzed. Each surgeon decided whether to perform main tumor resection or pleural biopsy alone.Results The patients were grouped based on the surgical approaches: main tumor resection (resection group; n=83) and pleural biopsy only (O&C group; n=93). The resection group had better overall survival (OS; 10-year survival, 27.9% vs. 9.4%; median survival, 68.3 vs. 36.6 months; p < 0.01) and locoregional progression-free survival (10-year survival, 12.5% vs. 7.1%; median survival, 19.6 vs. 10.6 months; p < 0.01) than the O&C group. Similar results were found for OS in patients who received tyrosine kinase inhibitors (TKIs) as first-line therapy (10-year survival, 49.2% vs. 15.0%; median survival, 72.2 vs. 45.4 months; p=0.03), patients who did not undergo TKIs treatment (10-year survival, 29.4% vs. 9.2%; median survival, 82.4 vs. 23.8 months; p < 0.01), and patients with positive target gene mutation (10-year survival, 31.7% vs. 10.1%; median survival, 72.2 vs. 33.7 months; p < 0.01). In multivariate analysis, pleural biopsy only (hazard ratio, 1.73; p=0.04) was a significant predictor of OS.Conclusion Main tumor resection can improve survival in patients with lung adenocarcinoma who had unexpected pleural metastasis during operation.
- 15 October 2025
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 57 (4) , 981-988
Open AccessLong-term Survival Outcomes of Surgical Resection for Lung Adenocarcinoma with Intraoperatively Diagnosed Pleural Metastasis: Target Treatment Era
Purpose This study aimed to evaluate the clinical impact of main tumor resection on long-term survival compared with pleural biopsy alone in patients with lung adenocarcinoma who were intraoperatively diagnosed with pleural metastasis.Materials and Methods A total of 176 patients with adenocarcinoma who had unexpected pleural metastasis detected during surgery from 2002 to 2021 were retrospectively analyzed. Each surgeon decided whether to perform main tumor resection or pleural biopsy alone.Results The patients were grouped based on the surgical approaches: main tumor resection (resection group; n=83) and pleural biopsy only (O&C group; n=93). The resection group had better overall survival (OS; 10-year survival, 27.9% vs. 9.4%; median survival, 68.3 vs. 36.6 months; p < 0.01) and locoregional progression-free survival (10-year survival, 12.5% vs. 7.1%; median survival, 19.6 vs. 10.6 months; p < 0.01) than the O&C group. Similar results were found for OS in patients who received tyrosine kinase inhibitors (TKIs) as first-line therapy (10-year survival, 49.2% vs. 15.0%; median survival, 72.2 vs. 45.4 months; p=0.03), patients who did not undergo TKIs treatment (10-year survival, 29.4% vs. 9.2%; median survival, 82.4 vs. 23.8 months; p < 0.01), and patients with positive target gene mutation (10-year survival, 31.7% vs. 10.1%; median survival, 72.2 vs. 33.7 months; p < 0.01). In multivariate analysis, pleural biopsy only (hazard ratio, 1.73; p=0.04) was a significant predictor of OS.Conclusion Main tumor resection can improve survival in patients with lung adenocarcinoma who had unexpected pleural metastasis during operation.
- 22 April 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (8) , 110095
Clinical implications of selective right paratracheal lymph node dissection in patients with early-stage esophageal Cancer: Propensity score-matched analysis
- 22 April 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (8) , 110095
Clinical implications of selective right paratracheal lymph node dissection in patients with early-stage esophageal Cancer: Propensity score-matched analysis
- 9 January 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (5) , 109591
Long-term oncologic outcomes of robot-assisted versus conventional open esophagectomy for esophageal cancer: Propensity-score matched anaylsis
- 9 January 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (5) , 109591
Long-term oncologic outcomes of robot-assisted versus conventional open esophagectomy for esophageal cancer: Propensity-score matched anaylsis
- 7 December 2024
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 38 (1)
Gastric conduit in patients with previous endoscopic resection of the stomach for esophageal squamous cell carcinoma
Summary: This study investigated the clinical outcomes of gastric conduits for esophageal reconstruction in esophageal squamous cell carcinoma (ESCC) patients who had previously undergone endoscopic resection of the stomach. From January 2006 to April 2023, a total of 1964 patients underwent surgery for esophageal cancer at our institution. After initially excluding 125 of these cases due to a histology other than ESCC, we identified 147 patients in the remaining population who had previously undergone a gastric endoscopic resection, among which 56 patients (67.0 ± 6.5 years) were included in the present study cohort. A gastric conduit event was defined as any new lesions at the gastric conduit. The diagnoses of a previous gastric lesion included early gastric cancer (EGC) in 32 patients (57.1%), adenoma in 23 patients (41.1%), and dysplasia in 1 (1.8%) patient. The endoscopic procedures involved an endoscopic submucosal dissection (ESD) in 36 patients (64.3%) and an endoscopic mucosal resection in 20 patients (35.7%). The 10-year event-free survival rate for the gastric conduit was 43.7%. Five patients were diagnosed with metachronous gastric neoplasm (EGC in two and adenoma in three patients). Endoscopic procedures were available for all five cases, but one patient with a metachronous EGC required a colon interposition with a total gastrectomy. In ESCC patients who have undergone an endoscopic resection of their gastric lesions, subsequent esophageal reconstruction with a gastric conduit could be a viable option if followed by regular endoscopic surveillance for the early detection and endoscopic curability of any lesions.
- 7 December 2024
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 38 (1)
Gastric conduit in patients with previous endoscopic resection of the stomach for esophageal squamous cell carcinoma
Summary: This study investigated the clinical outcomes of gastric conduits for esophageal reconstruction in esophageal squamous cell carcinoma (ESCC) patients who had previously undergone endoscopic resection of the stomach. From January 2006 to April 2023, a total of 1964 patients underwent surgery for esophageal cancer at our institution. After initially excluding 125 of these cases due to a histology other than ESCC, we identified 147 patients in the remaining population who had previously undergone a gastric endoscopic resection, among which 56 patients (67.0 ± 6.5 years) were included in the present study cohort. A gastric conduit event was defined as any new lesions at the gastric conduit. The diagnoses of a previous gastric lesion included early gastric cancer (EGC) in 32 patients (57.1%), adenoma in 23 patients (41.1%), and dysplasia in 1 (1.8%) patient. The endoscopic procedures involved an endoscopic submucosal dissection (ESD) in 36 patients (64.3%) and an endoscopic mucosal resection in 20 patients (35.7%). The 10-year event-free survival rate for the gastric conduit was 43.7%. Five patients were diagnosed with metachronous gastric neoplasm (EGC in two and adenoma in three patients). Endoscopic procedures were available for all five cases, but one patient with a metachronous EGC required a colon interposition with a total gastrectomy. In ESCC patients who have undergone an endoscopic resection of their gastric lesions, subsequent esophageal reconstruction with a gastric conduit could be a viable option if followed by regular endoscopic surveillance for the early detection and endoscopic curability of any lesions.
- Open Access
- 8 August 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57 (5) , 467-476
Prognostic Implications of Selective Dissection of Left Lower Paratracheal Lymph Nodes in Patients with Left-Sided Non-Small Cell Lung Cancer
Hyo Kyen Park, M.D., Yelee Kwon, M.D., Geun Dong Lee, M.D., Ph.D., Sehoon Choi, M.D., Ph.D., Hyeong Ryul Kim, M.D., Ph.D., Yong-Hee Kim, M.D., Ph.D., Dong Kwan Kim, M.D., Ph.D., Seung-Il Park, M.D., Ph.D., Jae Kwang Yun, M.D., Ph.D.. J Chest Surg 2024;57:467-76. https://doi.org/10.5090/jcs.24.022
- 8 August 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57 (5) , 467-476
Open AccessPrognostic Implications of Selective Dissection of Left Lower Paratracheal Lymph Nodes in Patients with Left-Sided Non-Small Cell Lung Cancer
Hyo Kyen Park, M.D., Yelee Kwon, M.D., Geun Dong Lee, M.D., Ph.D., Sehoon Choi, M.D., Ph.D., Hyeong Ryul Kim, M.D., Ph.D., Yong-Hee Kim, M.D., Ph.D., Dong Kwan Kim, M.D., Ph.D., Seung-Il Park, M.D., Ph.D., Jae Kwang Yun, M.D., Ph.D.. J Chest Surg 2024;57:467-76. https://doi.org/10.5090/jcs.24.022
- Open Access
- 22 November 2021
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 34 (3) , 354-360
Mini-thoracotomy and full-sternotomy approach for reoperative mitral valve surgery after a previous sternotomy
: OBJECTIVES: Right mini-thoracotomy approach may enhance the visualization of mitral valve (MV) visualization during redo MV surgery, thereby minimizing the risk of reoperative median sternotomy. We described the clinical outcomes of redo MV surgery by mini-thoracotomy and full-sternotomy approach. METHODS: Of 730 consecutive adult patients who underwent redo MV surgery between 2002 and 2018 at our institution, we identified 380 patients (age: 56.0 [14.8] years) after excluding those who underwent concomitant aortic valve or coronary artery surgeries. RESULTS: The clinical outcomes in patients who underwent mini-thoracotomy (MINI group; n = 168) and full-sternotomy (STERN group; n = 218) were described. The early and overall mortality in the MINI group was 4.3% (7/162) and 17.3% (28/162), with the rates of early major complications as follows: low cardiac output syndrome, 5.6% (9/162); early stroke, 6.8% (11/162); new-onset dialysis, 6.2% (10/162); prolonged ventilation, 15.4% (25/162); and postoperative bleeding requiring exploration, 7.4% (12/162). In the STERN group, the early mortality was 11.0% (24/218), whereas the risk of low cardiac output syndrome, early stroke, new-onset dialysis, prolonged ventilation, and postoperative bleeding was 12.4% (27/218), 14.2% (31/218), 17.0% (37/218), 33.0% (72/218), and 10.1% (22/218), respectively. The duration of intensive care unit and hospital stay was 2.0 [range 1.0, 3.0] and 8.0 [6.0, 13.0], respectively, in the MINI group and 3.0 [2.0, 7.0] and 14.0 [8.0, 29.0], respectively, in the STERN group. CONCLUSIONS: Mini-thoracotomy may be a viable alternative to conventional sternotomy for redo MV surgery.
- 22 November 2021
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 34 (3) , 354-360
Open AccessMini-thoracotomy and full-sternotomy approach for reoperative mitral valve surgery after a previous sternotomy
: OBJECTIVES: Right mini-thoracotomy approach may enhance the visualization of mitral valve (MV) visualization during redo MV surgery, thereby minimizing the risk of reoperative median sternotomy. We described the clinical outcomes of redo MV surgery by mini-thoracotomy and full-sternotomy approach. METHODS: Of 730 consecutive adult patients who underwent redo MV surgery between 2002 and 2018 at our institution, we identified 380 patients (age: 56.0 [14.8] years) after excluding those who underwent concomitant aortic valve or coronary artery surgeries. RESULTS: The clinical outcomes in patients who underwent mini-thoracotomy (MINI group; n = 168) and full-sternotomy (STERN group; n = 218) were described. The early and overall mortality in the MINI group was 4.3% (7/162) and 17.3% (28/162), with the rates of early major complications as follows: low cardiac output syndrome, 5.6% (9/162); early stroke, 6.8% (11/162); new-onset dialysis, 6.2% (10/162); prolonged ventilation, 15.4% (25/162); and postoperative bleeding requiring exploration, 7.4% (12/162). In the STERN group, the early mortality was 11.0% (24/218), whereas the risk of low cardiac output syndrome, early stroke, new-onset dialysis, prolonged ventilation, and postoperative bleeding was 12.4% (27/218), 14.2% (31/218), 17.0% (37/218), 33.0% (72/218), and 10.1% (22/218), respectively. The duration of intensive care unit and hospital stay was 2.0 [range 1.0, 3.0] and 8.0 [6.0, 13.0], respectively, in the MINI group and 3.0 [2.0, 7.0] and 14.0 [8.0, 29.0], respectively, in the STERN group. CONCLUSIONS: Mini-thoracotomy may be a viable alternative to conventional sternotomy for redo MV surgery.
- Open Access
- 5 June 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (3) , 221-223
Eighteen Years of Follow-up after Resection of a Giant Coronary Artery Aneurysm and Reconstruction with a Vein Graft
Yelee Kwon, M.D., Chong Bin Park, M.D., Ph.D., Pil Je Kang, M.D., Won Chul Cho, M.D., Ph.D.. Korean Journal of Thoracic and Cardiovascular Surgery 2021;54:221-3. https://doi.org/10.5090/jcs.20.109
- 5 June 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (3) , 221-223
Open AccessEighteen Years of Follow-up after Resection of a Giant Coronary Artery Aneurysm and Reconstruction with a Vein Graft
Yelee Kwon, M.D., Chong Bin Park, M.D., Ph.D., Pil Je Kang, M.D., Won Chul Cho, M.D., Ph.D.. Korean Journal of Thoracic and Cardiovascular Surgery 2021;54:221-3. https://doi.org/10.5090/jcs.20.109
- Open Access
Endovascular Repair of an Aortoesophageal Fistula and Fast-growing Thoracic Aortic Pseudoaneurysm Caused by Ingestion of a Fishbone
Thoracic endovascular aortic repair has been preferred over surgery for aortic lesions owing to its minimal invasiveness. Here we report the successful endovascular repair of a thoracic aortic pseudoaneurysm after esophageal perforation induced by accidental ingestion of a fishbone.
Open AccessEndovascular Repair of an Aortoesophageal Fistula and Fast-growing Thoracic Aortic Pseudoaneurysm Caused by Ingestion of a Fishbone
Thoracic endovascular aortic repair has been preferred over surgery for aortic lesions owing to its minimal invasiveness. Here we report the successful endovascular repair of a thoracic aortic pseudoaneurysm after esophageal perforation induced by accidental ingestion of a fishbone.
- Open Access
- 20 April 2021
- Published by Wiley
Endovascular Repair of an Aortoesophageal Fistula and Fast-growing Thoracic Aortic Pseudoaneurysm Caused by Ingestion of a Fishbone
Thoracic endovascular aortic repair has been preferred over surgery for aortic lesions owing to its minimal invasiveness. Here we report the successful endovascular repair of a thoracic aortic pseudoaneurysm after esophageal perforation induced by accidental ingestion of a fishbone.
- 20 April 2021
- Published by Wiley
Open AccessEndovascular Repair of an Aortoesophageal Fistula and Fast-growing Thoracic Aortic Pseudoaneurysm Caused by Ingestion of a Fishbone
Thoracic endovascular aortic repair has been preferred over surgery for aortic lesions owing to its minimal invasiveness. Here we report the successful endovascular repair of a thoracic aortic pseudoaneurysm after esophageal perforation induced by accidental ingestion of a fishbone.